Conferences and Financial Calendar
The financial calendar is for indicative purposes only and the Group could change its publication dates should it deem it necessary.
Valneva will present two posters: "Burden of Illness and Paucity of Treatment of the Mosquito-Borne Chikungunya Virus (CHIKV)” and “The Economic Burden of the Globally Spreading Chikungunya Virus: A Systematic and Targeted Review.”
Valneva will present on the Phase 3 clinical development of its single-shot chikungunya vaccine candidate on November 1, 2022 at 10:15am PST during an in-person scientific session.
“Progress of Clinical Development of a Live-Attenuated Single Shot Chikungunya Vaccine Candidate”.